Turnstone Biologics Corp. Announces Pricing Of $80M Upsized Initial Public Offering Of 6.66M Shares Of Common Stock At A price Of $12/Share; Shares To Open For Trade Today
Portfolio Pulse from Happy Mohamed
Turnstone Biologics Corp. (NASDAQ:TSBX) has priced its upsized initial public offering (IPO) of 6.66 million shares at $12 per share, expecting to raise $80 million. The shares are set to begin trading on the Nasdaq Global Select Market under the symbol 'TSBX'. The underwriters have a 30-day option to purchase up to an additional 1 million shares.
July 21, 2023 | 2:11 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Turnstone Biologics' IPO is priced at $12 per share, with the company expecting to raise $80 million. The shares will start trading on the Nasdaq under the symbol 'TSBX'.
The IPO pricing and the expected proceeds from the offering are key factors that could influence the stock's performance in the short term. The news is highly relevant and important for investors in TSBX as it provides details about the company's IPO, which is a significant event that could impact the stock's price.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100